Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pro-inflammatory GPR75 and anti-apoptotic phospholipase signaling pathways contribute to the ameliorating effect of soluble epoxide hydrolase inhibition on chronic experimental autoimmune encephalomyelitis in mice.
Horat MF, Senol SP, Bahceli O, Temiz-Resitoglu M, Sahan-Firat S, Sevim S, Tunctan B. Horat MF, et al. Among authors: senol sp. Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):9-16. doi: 10.14715/cmb/2023.69.10.2. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37953590
Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner.
Biliktu M, Senol SP, Temiz-Resitoglu M, Guden DS, Horat MF, Sahan-Firat S, Sevim S, Tunctan B. Biliktu M, et al. Among authors: senol sp. Inflammopharmacology. 2020 Dec;28(6):1509-1524. doi: 10.1007/s10787-020-00691-w. Epub 2020 Mar 3. Inflammopharmacology. 2020. PMID: 32128702
Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model.
Cagli A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B. Cagli A, et al. Among authors: senol sp. Drug Dev Res. 2021 Sep;82(6):815-825. doi: 10.1002/ddr.21786. Epub 2021 Feb 8. Drug Dev Res. 2021. PMID: 33559150
mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats.
Guden DS, Temiz-Resitoglu M, Senol SP, Kibar D, Yilmaz SN, Tunctan B, Malik KU, Sahan-Firat S. Guden DS, et al. Among authors: senol sp. Can J Physiol Pharmacol. 2021 Sep;99(9):921-934. doi: 10.1139/cjpp-2020-0487. Epub 2021 Feb 27. Can J Physiol Pharmacol. 2021. PMID: 33641344
Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock.
Tunctan B, Senol SP, Temiz-Resitoglu M, Yilmaz DE, Guden DS, Bahceli O, Horat MF, Sahan-Firat S, Sari AN, Falck JR, Anugu RR, Malik KU. Tunctan B, et al. Among authors: senol sp. J Cardiovasc Pharmacol. 2022 Aug 1;80(2):276-293. doi: 10.1097/FJC.0000000000001265. J Cardiovasc Pharmacol. 2022. PMID: 35323151
NF-κB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock.
Sahan-Firat S, Temiz-Resitoglu M, Guden DS, Senol SP, Sari AN, Cil M, Unsal D, Korkmaz B, Tunctan B, Malik KU, Buharalioglu CK. Sahan-Firat S, et al. Among authors: senol sp. Clin Exp Pharmacol Physiol. 2019 Feb;46(2):173-182. doi: 10.1111/1440-1681.13045. Clin Exp Pharmacol Physiol. 2019. PMID: 30347478
Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats.
Temiz-Resitoglu M, Guden DS, Senol SP, Vezir O, Sucu N, Kibar D, Yılmaz SN, Tunctan B, Malik KU, Sahan-Firat S. Temiz-Resitoglu M, et al. Among authors: senol sp. J Cardiovasc Pharmacol. 2022 Mar 1;79(3):355-367. doi: 10.1097/FJC.0000000000001187. J Cardiovasc Pharmacol. 2022. PMID: 34840266
13 results